These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 21524743)
1. [Calcific uremic arteriolopathy. a case report and review of the literature]. Vassallo M; Bello I; Hamana L; Ferrer A; Rojas F; Cantele H Rev Clin Esp; 2011; 211(7):e37-41. PubMed ID: 21524743 [TBL] [Abstract][Full Text] [Related]
2. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. Basile C; Montanaro A; Masi M; Pati G; De Maio P; Gismondi A J Nephrol; 2002; 15(6):676-80. PubMed ID: 12495283 [TBL] [Abstract][Full Text] [Related]
3. Pivotal role of paricalcitol in the treatment of calcific uremic arteriolopathy in the presence of a parathyroid adenoma. Vargemezis V; Liakopoulos V; Kriki P; Panagoutsos S; Leontsini M; Passadakis P; Thodis E Am J Kidney Dis; 2010 Jan; 55(1):144-7. PubMed ID: 19481317 [TBL] [Abstract][Full Text] [Related]
4. Calciphic uremic arteriolopathy complicating chronic kidney disease. Rodríguez-Pérez S; Ramirez-Rivera J; Jaume-Anselmi F; Torres AB Bol Asoc Med P R; 2008; 100(3):47-50. PubMed ID: 19227717 [TBL] [Abstract][Full Text] [Related]
5. Medical image. A rare but fatal complication of end stage renal disease: calcific uremic arteriolopathy. Aarti M; Shweta P; Ankur S; Swathi B; Jiang J; Ambika B N Z Med J; 2012 Mar; 125(1352):106-9. PubMed ID: 22472720 [No Abstract] [Full Text] [Related]
6. Recognizing calcific uremic arteriolopathy in autoimmune disease: an emerging mimicker of vasculitis. Lee JL; Naguwa SM; Cheema G; Gershwin ME Autoimmun Rev; 2008 Sep; 7(8):638-43. PubMed ID: 18774119 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous necrosis from calcific uremic arteriolopathy. Coates T; Kirkland GS; Dymock RB; Murphy BF; Brealey JK; Mathew TH; Disney AP Am J Kidney Dis; 1998 Sep; 32(3):384-91. PubMed ID: 9740153 [TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous necrosis by calcific uremic arteriolopathy. Galimberti RL; Farias Edos R; Parra IH; Algranati L; Kowalczuk A; Imperiali N; Greloni GC; Galimberti G Int J Dermatol; 2005 Feb; 44(2):101-6. PubMed ID: 15689205 [TBL] [Abstract][Full Text] [Related]
16. Calcific uremic arteriolopathy: overview for the nurse. Anderson KG AACN Adv Crit Care; 2013; 24(3):285-300. PubMed ID: 23880751 [TBL] [Abstract][Full Text] [Related]
17. Fulminant metastatic calcinosis with cutaneous necrosis in a child with end-stage renal disease and tertiary hyperparathyroidism. Zouboulis CC; Blume-Peytavi U; Lennert T; Stavropoulos PG; Schwarz A; Runkel N; Trautmann C; Orfanos CE Br J Dermatol; 1996 Oct; 135(4):617-22. PubMed ID: 8915159 [TBL] [Abstract][Full Text] [Related]